Skip to main content
. 2022 May 23;14(2):380–389. doi: 10.1177/21925682221105005

Table 2.

DXA and laboratory results in the patients undergoing primary spine surgery.

Parameter Discectomy (n=30) Decompression (n=145) Fusion (n=75) P-value
DXA
BMD left hip (g/cm2) 1.03 (.93 to 1.10) .95 (.91 to .97) .99 (.92 to 1.02) .21
T-score left hip -.4 (-.9 to .3) -.8 (-1.0 to -.5) -.5 (-1.1 to .0) .38
BMD right hip (g/cm2) 1.01 (.91 to 1.06) .95 (.90 to .99) .92 (.88 to 1.00) .22
T-score right hip -.3 (-.9 to .1) -.8 (-1.0 to -.3) -.8 (-1.2 to -.3) .42
BMD lumbar spine (g/cm2) 1.16 (1.09 to 1.24) 1.19 (1.15 to 1.25) 1.08 (1.03 to 1.18) .03
T-score lumbar spine -.3 (-.7 to .6) .1 (-.4 to .5) -.7 (-1.3 to .0) .04
T-score lowest -.9 (-1.2 to -.5) -1.0 (-1.2 to -.7) -1.4 (-1.9 to -.7) .32
Osteopenia (%) 9 (30.0%) 63 (43.4%) 31 (41.3%) .40
Osteoporosis (%) 2 (6.7%) 16 (11.0%) 11 (14.7%) .49
- Diagnosed before? 0/2 (.0%) 4/16 (25.0%) 4/11 (36.4%)
- Women 2/16 (12.5%) 10/88 (11.4%) 9/54 (16.7%)
- Men 0/14 (.0%) 6/57 (10.5%) 2/21 (9.5%)
Laboratory
Calcium (mmol/l) 2.35 (2.30 to 2.40) 2.35 (2.32 to 2.37) 2.32 (2.30 to 2.34) .18
25-OH-D3 (nmol/l) 54.9 (42.2 to 74.5) 55.9 (47.4 to 65.1) 50.8 (35.9 to 57.6) .16
- Vitamin D deficiency (n, %) 21/30 (70.0%) 92/129 (71.3%) a 51/66 (77.3) a .63
PTH (pmol/l) 5.46 (4.30 to 6.03) 5.10 (4.44 to 5.30) 5.11 (4.70 to 5.38) .69
- HPT (n, %) 3/24 (12.5%) a 14/98 (14.3%) a 8/49 (16.3%) a .90
Phosphate (pmol/l) 3.00 (2.80 to 3.20) 3.00 (2.90 to 3.10) 3.10 (2.80 to 3.20) .98
ALP (U/l) 77.0 (69.0 to 85.0) 73.5 (70.0 to 77.0) 72.0 (65.0 to 77.0) .19
Creatinine (mg/dl) .89 (.81 to .97) .89 (.84 to .94) .86 (.80 to .92) .65
CRP (mg/dl) .24 (.00 to .40) .10 (.10 to .20) .20 (.10 to .60) .03
Leukocytes (G/l) 8.15 (6.90 to 9.50) 7.00 (6.60 to 7.50) 7.10 (6.40 to 8.00) .22
Hemoglobin (g/dl) 13.4 (13.0 to 13.9) 14.0 (13.6 to 14.2) 13.7 (13.5 to 14.2) .66

Results are presented as median with 95% confidence intervals or n (%). Bold indicates significant differences (P < .05).

aindicates deviating number of measured patients for the individual parameter. HPT: hyperparathyroidism.